Nautic Partners to invest in infusion therapies provider KabaFusion
KabaFusion’s management team will remain significant investors and continue to lead the company, while Novo Holdings will exit its investment.
27 August 2025•1 min read
KabaFusion’s management team will remain significant investors and continue to lead the company, while Novo Holdings will exit its investment.
